High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection.
Overview
publication date
- September 15, 2013
published in
- Transplantation Journal
Research
keywords
- Graft Rejection
- Immunoglobulins, Intravenous
- Pancreas Transplantation
Identity
Scopus Document Identifier
- 84883513938
Digital Object Identifier (DOI)
- 10.1097/TP.0b013e3182a04974
PubMed ID
- 23995870
Additional Document Info
has global citation frequency
volume
- 96
issue
- 5